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Abstract Fidelity of chromosome segregation is monitored
by the spindle assembly checkpoint (SAC). Key components
of the SAC include MAD1, MAD2, BUB1, BUB3, BUBR1,
and MPS1. These proteins accumulate on kinetochores in
early prometaphase but are displaced when chromosomes
attach to microtubules and/or biorient on the mitotic spindle.
As a result, stable attachment of the final chromosome sat-
isfies the SAC, permitting activation of the anaphase promot-
ing complex/cyclosome (APC/C) and subsequent anaphase
onset. SAC satisfaction is reversible, however, as addition of
taxol during metaphase stops cyclin B1 degradation by the
APC/C. We now show that targeting MAD1 to kinetochores
duringmetaphase is sufficient to reestablish SAC activity after
initial silencing. Using rapamycin-induced heterodimerization
of FKBP-MAD1 to FRB-MIS12 and livemonitoring of cyclin
B1 degradation, we show that timed relocalization of MAD1
during metaphase can stop cyclin B1 degradation without
affecting chromosome-spindle attachments. APC/C inhibition
represented true SAC reactivation, as FKBP-MAD1 required
an intact MAD2-interaction motif and MPS1 activity to ac-
complish this. Our data show that MAD1 kinetochore locali-
zation dictates SAC activity and imply that SAC regulatory
mechanisms downstream of MAD1 remain functional in
metaphase.
Keywords Spindle checkpoint .Metaphase .MAD1 .
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Introduction
Whole chromosome alterations to the karyotype are hazardous
to eukaryotic cells (Sheltzer and Amon 2011). As such, a
surveillance mechanism named the spindle assembly check-
point (SAC) has evolved to protect cells from chromosome
segregation errors during cell divisions. Our recent compara-
tive genomic analysis showed that this checkpoint was likely
present in the last eukaryotic common ancestor, since most
protein components of the SAC can be identified in species
throughout the eukaryotic tree of life (Vleugel et al. 2012).
The SAC monitors the state of attachment of chromosomes to
microtubules of the mitotic spindle and halts the cell cycle
until all chromosomes have achieved stable biorientation.
Unattached kinetochores and/or kinetochores of non-
bioriented chromosomes recruit a subset of SAC components
that contribute to the generation of a wait-anaphase signal
(Musacchio and Salmon 2007; Kops and Shah 2012).
Central to this is the MAD1-MAD2 complex that is stably
associated with unattached kinetochores (Mapelli and
Musacchio 2007). MAD1-MAD2 catalyzes production of an
inhibitor of the anaphase-promoting complex/cyclosome
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(APC/C), resulting in maintenance of sister chromatid cohe-
sion and of the mitotic state (De Antoni et al. 2005; Kulukian
et al. 2009; Simonetta et al. 2009). A current model of SAC
signaling is as follows: various activities at kinetochores,
including BUB1, MPS1, and Rod-ZW10-Zwilch, contribute
to recruitment of the MAD1-MAD2 complex (Basto et al.
2000; Brady and Hardwick 2000; Chan et al. 2000; Martin-
Lluesma et al. 2002; Meraldi et al. 2004; Kops et al. 2005; Liu
et al. 2006; Klebig et al. 2009; Santaguida et al. 2010;
Sliedrecht et al. 2010; Maciejowski et al. 2010; Kim et al.
2012; London and Biggins 2014; Moyle et al. 2014). This
complex in turn binds soluble MAD2 molecules and converts
these into a form that allows association with CDC20, an
essential mitotic cofactor of the APC/C (Mapelli and
Musacchio 2007). The MAD2-CDC20 complex then binds
BUBR1/BUB3 and this four-subunit protein complex, now
referred to as the MCC (mitotic checkpoint complex) is di-
rected to the APC/C (Sudakin et al. 2001; Fang 2002; Morrow
et al. 2005; Herzog et al. 2009; Tipton et al. 2011; Chao et al.
2012; Tang et al. 2001; Davenport et al. 2006; Kulukian et al.
2009; Elowe et al. 2010; Han et al. 2013). MCC-bound APC/
C is incapable of poly-ubiquitinating its metaphase substrates,
securin and cyclin B1, at least in large part due to the actions
of BUBR1, which occupies a substrate-recognition site on
CDC20 and likely has additional inhibitory interactions with
the APC/C (Lara-Gonzalez et al. 2011; Chao et al. 2012; Tang
et al. 2001; King et al. 2007; Burton and Solomon 2007;
Sczaniecka et al. 2008; Pines 2011; Han et al. 2013).
Stable attachment of kinetochores to microtubules causes
removal of SAC proteins, thereby negating their ability to
generate MCC (Kops and Shah 2012). It was recently shown
by Maldonado and Kapoor that removal of MAD1 is a key
step in shutting down SAC signaling at kinetochores.
Preventing its release after microtubule binding by tethering
it to the constitutive kinetochore protein MIS12 delayed ana-
phase onset (Maldonado and Kapoor 2011). In agreement
with this, we showed previously that similar tethering of
MPS1 prevented anaphase in human cells and this coincided
with persistent MAD1 localization to attached, bioriented
kinetochores (Jelluma et al. 2010). While attachment of kinet-
ochores leads to progressive weakening of SAC signaling
(Collin et al. 2013), full SAC silencing awaits stable
biorientation of all chromosomes. In addition to removal of
MAD1 from kinetochores, such silencing requires disassem-
bly of MCC and release of APC/C activity, followed by
degradation of cyclin B1 and securin (Reddy et al. 2007;
Westhorpe et al. 2011; Varetti et al. 2011; Teichner et al.
2011; Mansfeld et al. 2011; Foster and Morgan 2012;
Uzunova et al. 2012). SAC silencing is, however, reversible.
Addition of taxol to cells that had initiated cyclin B1 degra-
dation at metaphase was able to rapidly halt further cyclin B1
degradation (Clute and Pines 1999; Dick and Gerlich 2013).
Since taxol reduces inter-sister tension and allows a subset of
kinetochore-microtubule interactions to be released (Waters
et al. 1998), SAC reactivation by taxol in metaphase most
likely involved full reactivation of the SAC signaling cascade
in response to loss of attachment.
We set out to examine if MAD1 kinetochore-binding is the
determining factor in switching the SAC between the ON and
OFF state. To this end, MAD1 localization to kinetochores
was temporally controlled by chemically induced
heterodimerization using the FRB-FKBP12 system (Rivera
et al. 1996). Conditional targeting of MAD1 to kinetochores
after metaphase and live monitoring of cyclin B1 showed that
MAD1 relocalization was sufficient to reactivate the SAC
after it was initially silenced.
Results and discussion
Constitutive tethering ofMAD1 to kinetochores by fusing it to
the KMNnetwork componentMIS12 prevents SAC silencing in
human cells (Maldonado and Kapoor 2011). To examine if
MAD1 tethering to kinetochores after SAC silencing is sufficient
to reactivate the SAC, we made use of the rapamycin-inducible
dimerization of FRBwith FKBP12 (Fig. 1a) (Rivera et al. 1996).
MIS12 was fused to FRB and stably expressed in HeLa-Flp-in
cells that contained a doxycycline-inducible expression cassette
for either wild-type (WT) FKBP-MAD1 or a mutant version
(K541/L543A) that perturbs MAD2 binding (MAD1AA, (Sironi
et al. 2002)) (Fig. 1b and S1). MIS12-FRB could be visualized
by virtue of a C-terminal FLAG-tagRFP moiety, while the
MAD1 proteins could be visualized via an N-terminal eYFP
moiety. As expected, 30 min of rapamycin addition to mitotic
cells caused accumulation of both FKBP-MAD1 variants on
kinetochores (Fig. 1c). In the absence of rapamycin, metaphase
kinetochores were devoid of FKBP-MAD1 (Fig. 1c).
To verify that conditional tethering of MAD1 to kineto-
chores could delay anaphase onset like previously shown for
direct fusion of MAD1 to MIS12 (Maldonado and Kapoor
2011), we added rapamycin to a population of cells in G2 phase
and monitored mitotic progression by live cell differential
interference contrast (DIC) imaging. As shown in Fig. 2a,
progression through mitosis was delayed when cells expressing
MIS12-FRB and FKBP-MAD1WT were treated with
rapamycin. In contrast, mitotic progression occurred with nor-
mal timing in the absence of rapamycin (Fig. 2a, DMSO) or
when rapamycin was added to cells expressing the FKBP-
MAD1AA mutant. These finding were corroborated by moni-
toring the levels of cyclin B1-mCherry: degradation of cyclin
B1 occurred with normal kinetics in the three control conditions
but was strongly inhibited in rapamycin-treated cells expressing
FKBP-MAD1WT (Fig. 2b). This implied that the observed
mitotic delays were due to persistent inhibition of the APC/C
by the SAC. SAC activity under these conditions was not due to
destabilization of kinetochore-microtubule interactions:
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rapamycin-treated FKBP-MAD1WT cells were able to rapidly
align their chromosomes and remained arrested in mitosis
without loss of metaphase plate integrity (Fig. 2c and S2), and
the amount and appearance of cold-stable microtubules at
metaphase were indistinguishable from control (Fig. 2d).
Thus far, our findings indicate that chemically induced
targeting of MAD1 to kinetochores recapitulated published
phenotypes of the constitutively kinetochore-tethered MIS12-
MAD1 fusion protein (Maldonado and Kapoor 2011). To
examine if MAD1 can be recruited to kinetochores in meta-
phase, we allowed cells to reach metaphase before adding
rapamycin. To this end, cells were treated with the proteasome
inhibitor MG132 for 30min after which rapamycin was added
for an additional 20 min. Live cell and immunofluorescence
imaging showed that MAD1was efficiently recruited to meta-
phase kinetochores under these conditions (Fig. 3a–c).
Moreover, endogenous MAD2 accumulated on metaphase
kinetochores of rapamycin-treated cells expressing FKBP-
MAD1WT (Fig. 3c).
To time the speed with which MAD1 could be recruit-
ed to kinetochores in metaphase, we followed MG132-
treated cells by time-lapse imaging. Kinetochores were
monitored by imaging MIS12-FRB-tagRFP and cells were
determined to be in metaphase when all kinetochores had
aligned on the cell’s equator. Clear MAD1 kinetochore
binding could be seen 10–15 min after addition of
rapamycin to metaphase cells, as evidenced by accumula-
tion of YFP signals to MIS12-tagRFP-positive kineto-
chores (Fig. 3a). This timing was comparable for the
two MAD1 variants. The induced heterodimerization
was relatively slow compared to the speed with which
two soluble proteins can be induced to interact, and this
may be due to the geometry or microtubule occupancy of
the metaphase kinetochore.
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Fig. 1 Conditional tethering of
MAD1 to kinetochores in human
cells. a Schematic representation
of the experimental system to
conditionally relocalize MAD1
to kinetochores. b Immunoblots
of tubulin, cyclin B1, and eYFP-
FKBP-MAD1 (anti-MAD1)
from mitotic lysates of various
cell lines used in this study.
Doxycyline (+Dox) was added
16 h prior to harvesting.
c Immunostainings of eYFP-
FKBP-MAD1 (eYFP, detected
with anti-GFP antibody) and
kinetochores (CENP-C) in HeLa
Flp-in cells expressing MIS12-
FRB-FLAG and induced to
express eYFP-FKBP-MAD1
(WT, left or AA, right) by
addition of doxycycline for
4 h, and treated with DMSO
or rapamycin (rapa) for 30 min
in combination with MG132
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Like induced recruitment before mitosis (Figs. 1 and 2),
kinetochore recruitment of MAD1 in metaphase did not affect
chromosome alignment (Fig. 3b and S3), indicating that con-
ditional targeting of MAD1 in metaphase did not perturb
kinetochore-microtubule interactions. In support of this,
BUB1 and BUBR1—proteins that accumulate on
kinetochores in the absence of interkinetochore tension
(Skoufias et al. 2001; Taylor et al. 2001; Ditchfield et al.
2003; Hauf et al. 2003; Howell et al. 2004; Morrow et al.
2005; Famulski and Chan 2007)—were undetectable at meta-
phase kinetochores to which MAD1 was chemically recruited
(Fig. 3c).
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Fig. 2 Rapamycin-induced kinetochore tethering of MAD1 prior to mitosis
delays SAC silencing. a Time-lapse analysis of mitotic progression. HeLa
Flp-in cells expressing MIS12-FRB-FLAG were induced to express the
FKBP-MAD1 variants by addition of doxycycline 8 h prior to mitotic entry
following release from a single thymidine block. DMSO or rapamycin
were added 4 h after doxycycline addition. Data (n=50 cells per condi-
tion, one representative experiment of three is shown) indicate cumulative
fraction of cells that exit from mitosis (as scored by cell morphology
using DIC) at the indicated time after NEBD. b Time-lapse analysis of
cyclin B1 levels during mitotic progression. HeLa Flp-in cells expressing
MIS12-FRB-FLAG and cyclin B1-mCherry were induced to express the
FKBP-MAD1 variants by addition of doxycycline 8 h prior to mitotic
entry following release from a single thymidine block. DMSO or
rapamycin was added 4 h after doxycycline addition, after which cells
were monitored for cyclin B1-mCherry fluorescence every 5 min. Data
(n=40 cells per condition, one representative experiment of two is shown)
represent the level of mCherry fluorescence relative to the level at NEBD.
c Time-lapse analysis of mitotic progression of Flp-in HeLa cells express-
ingMIS12-FRB-FLAG, induced to express FKBP-MAD1WT by addition
of doxycycline for 8 h following release from a single thymidine block
and infected with a H2B-mCherry BacMam virus. DMSO or rapamycin
were added 4 h after doxycycline addition, after which cells were mon-
itored for morphology (DIC, single plane) and chromosomes (H2B-
mCherry, max projection) every 10 min. d Immunostainings of cold-
stable tubulin, kinetochores (CENP-C) and eYFP-FKBP-MAD1 (eYFP)
of HeLa cells expressing MIS12-FRB-FLAG and eYFP-FKBP-
MAD1WT and treated with rapamycin (rapa) for 30 min in combination
with MG132
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Together, these data show that MAD1 can be recruited
within 15 min to metaphase kinetochores without affecting
chromosome-spindle attachments. This therefore permitted
examination of the direct effects of kinetochore MAD1 on
SAC activity after metaphase.
To be certain that the SAC was silenced by the time
we forced MAD1 accumulation on kinetochores, we
continuously monitored cyclin B1 levels. Rapamycin
was added during the time-lapse experiment at the
height of a mitotic wave in the population that occurred
roughly 10 hours after release from a thymidine block,
when most cells were still in prometaphase. The reason-
ing was that in at least a fraction of the cells this would
allow MAD1 to reach significant levels at kinetochores
during degradation of cyclin B1 and before anaphase
initiation. In all control situations (FKBP-MAD1WT/
DMSO, FKBP-MAD1AA/DMSO, and FKBP-MAD1AA/
rapa), cyclin B1 was degraded with comparable kinetics,
and anaphase was initiated when most cyclin B1 was
degraded (Fig. 4). As expected, however, rapamycin
addition to cells expressing FKBP-MAD1WT resulted
in three different outcomes. First, cyclin B1 degradation
continued as normal, indicating that FKBP-MAD1WT
either did not efficiently target to kinetochores in these
cells or that it accumulated too late to prevent anaphase
onset. Second, cyclin B1 degradation never started, in-
dicating that MAD1 was targeted before the SAC was
silenced, similar to rapamycin addition before mitotic
entry (Figs. 1 and 2). Third, in roughly one third of
the cells (a similar fraction as cells showing significant
MAD2 relocalization (Fig. 3c)), cyclin B1 degradation
started but was subsequently abrogated (Fig. 4). This
behavior was never seen in any of the control situations
and showed at single cell level that relocalization of
MAD1 to kinetochores was able to reactivate the SAC
after it had initially been silenced. This reestablishment
of the SAC nevertheless still depended on MPS1 activity
as addition of the MPS1 inhibitor reversine (Santaguida
et al. 2010) lifted the reinstated block on cyclin B1
degradation and caused cells to initiate anaphase
(Fig. 4b and S4) without affecting kinetochore FKBP-
MAD1 levels (Fig. S4). It may be of interest to note that
all cells that restabilized cyclin B1 after rapamycin addi-
tion did so with at least 20 % of cyclin B1 left. This may
indicate that in this cell line, a significant amount of
cyclin B1 is needed to either maintain the mitotic state
and/or support SAC reactivation, in agreement with re-
cent reports (Dick and Gerlich 2013; Vázquez-Novelle
et al. 2014).
Our data show that forced localization of MAD1 to
metaphase kinetochores is sufficient to reactivate func-
tional SAC signaling after initial silencing. This implies
that MAD1 removal is a key step in SAC silencing.
Inhibition of pathways that recruit MAD1 (e.g., MPS1,
RZZ, BUB1) combined with activation of pathways that
displace MAD1 (e.g., dynein, spindly, kinetochore phos-
phatases (Wojcik et al. 2001; Howell et al. 2001; Yang
et al. 2007; Pinsky et al. 2009; Vanoosthuyse and
Hardwick 2009; Gassmann et al. 2010; Barisic et al.
2010; Famulski et al. 2011; Rosenberg et al. 2011)) will
thus be required to maintain the silenced state until
anaphase. Key unresolved issues are the nature and
spatiotemporal regulation of these pathways and their
relation to kinetochore-microtubule interactions. An in-
triguing player in this is MPS1. Persistent MPS1 local-
ization to metaphase kinetochores causes persistent
MAD1 kinetochore binding (Jelluma et al. 2010), so
MPS1 itself needs to be removed from kinetochores at
metaphase to allow MAD1 removal and SAC silencing.
At the same time, MPS1 remains active and able to
contribute to SAC signaling, since SAC reactivation by
conditional MAD1 tethering can be reverted by the
MPS1 inhibitor reversine (Fig. 4b). This implies that
at least part of the SAC signaling pathways that con-
tribute downstream of (or in parallel to) MAD1 kineto-
chore binding are still operational at metaphase. How
some aspects of MPS1 function are maintained so as to
assure SAC reactivation if required but some are re-
pressed so as to allow MAD1 removal is an interesting
challenge for further research.
Methods
Cell culture and reagents
HeLa Flp-in cells (gift from S. Taylor, University of
Manchester, England, UK) stably expressing a TetR, were
cultured in DMEM (4.5 g/L glucose, Lonza) supplemented
with 9 % fetal bovine serum (Tetracyclin-approved, Lonza),
50 μg/ml penicillin/streptomycin (Gibco), and 2 mM
Ultraglutamine (Lonza). All HeLa Flp-in cell lines stably
carrying doxycycline-inducible eYFP-FKBP-MAD1 con-
s t ruc ts were t ransfec ted wi th pcDNA5/FRT/TO
(Invitrogen) and pOG44 (Invitrogen) plasmid-carrying
Flp-recombinase. Selection and maintenance of stable
cel ls was done in medium supplemented with
200 μg/ml Hygromycin B (Roche) and 4 μg/ml
blasticidin (PAA Laboratories). HeLa Flp-in cell lines
stably expressing MIS12-FRB constructs were
transfected with Fugene HD (Roche), and stable lines
were selected for using 2 μg/ml puromycin (Sigma).
The HeLa Flp-in cell lines expressing cyclin B1-
mCherry were transfected with pcDNA3-cyclin B1-
mCherry and, stable cell lines were selected using
100 μg/ml Zeocin (Invivogen). The reagents thymidine
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(2 mM), reversine (500 nM), nocodazole (830 μM),
MG132 (10 μM), and doxycycline (1 μg/ml) were pur-
chased from Sigma-Aldrich and used at final concentra-
tions indicated. Rapamycin (100 nM) was purchased
from LC-Laboratories.
Plasmids
To create pcDNA5-eYFP-FKBP-MAD1WT and -MAD1AA
constructs, FKBP12 (a gift from Lukas Kapitein) was PCR-
amplified, ligated into pcDNA5-LAP-MAD1 using HindIII
sites, and the sequence was verified. MIS12-FRB-tagRFP
(MIS12-FRB-FLAG-tagRFP-IRES-PURO) and MIS12-
FRB-FLAG (MIS12-FRB-FLAG-IRES-PURO) were
constructed as follows: FRB was amplified from GFP-
FRB (Gift of Klaus Hahn) and inserted into pc3-FLAG-
tagRFP using EcoRI/ClaI sites to create pc3-FRB-
FLAG-tagRFP. MIS12 was amplified from pcDNA3-
MIS12-MPS1 (Jelluma et al. 2010) and inserted
(AscI/NheI) into pIRES-PURO (a gift of Susanne
Lens). FRB-FLAG-tagRFP was then amplified from
pc3-FRB-FLAG-tagRFP and inserted (NheI/NotI) into
pMIS12-IRES-PURO. pcDNA3-cyclin B1-mCherry plas-
mid was created by inserting a HindIII-NotI fragment of
pcDNA5-cyclin B1-mCherry into pcDNA3. The neomy-
cin selection gene of pcDNA3 was subsequently re-
placed with Zeocin using NotI/MluI.
Immunofluorescence
HeLa Flp-in cells were plated on 12-mm round coverslips
(No. 1.5) and induction of eYFP-FKBP-MAD1 was done
for 4.5 h. Cells were pre-extracted using 37 °C PEMT
(100 mM PIPES (pH 6.8), 1 mM MgCl2, 5 mM EGTA,
0.2 % Triton X-100) for 1 min after which cells were fixed
in 4 % paraformaldehyde/PBS for 15 min. Coverslips were
blocked in 3 % BSA/PBS for 1 h and primary antibody
incubations were done overnight at 4 °C. Coverslips were
washed three times in PBS/0.1 % TX-100 and subsequently
incubated with secondary antibodies plus DAPI for 1 h at
room temperature. Coverslips were washed twice in
PBS and mounted using ProLong Gold antifade
(Molecular Probes). Image acquisition was done on a
DeltaVision RT system (Applied Precis ion/GE
Healthcare) with a 100×1.40 numerical aperture (NA)
UPlanSApo objective (Olympus) and for deconvolution
SoftWorx (Applied Precision/GE Healthcare) was used.
Image analysis and quantification was done using
ImageJ and image preparation for figures was done
using Photoshop and Illustrator CS5 (Adobe Systems).
All graphs were created in Graphpad Prism 6.0d
(GraphPad Software, La Jolla, CA, USA).
The following primary antibodies were used for immunoflu-
orescence imaging: GFP (custom rabbit polyclonal, 1:10.000),
GFP (Abcam, mouse monocolonal 1:1,000), BUB1 (Bethyl,
A300-373A, 1:1,000), BUBR1 (Bethyl, A300-386A, 1:1,000),
MAD2 (custom rabbit polyclonal antibody, 1:1,000), andCENP-
C (MBL Life Science, polyclonal Guinea pig, PD030, 1:2,000).
Secondary antibodies used for immunofluorescence were highly
crossed absorbed anti-guinea pig Alexa Fluor 647, anti-rabbit
and anti-mouse Alexa Fluor 488, and 568, anti-rat Alexa Fluor
568 (Molecular Probes).
Live-cell imaging
Differential interference contrast (DIC) microscopy was
performed on an Olympus IX81 inverted microscope
equipped with a 10×0.30 NA CPlanFLN objective lens
(Olympus), Hamamatsu ORCA-ER camera and Cell^M
software (Olympus). Time-lapse imaging of cells plated in
a 12-well plate, was done at 37 °C and 5 % CO2 concen-
tration. Images were acquired every 5 min at 2×2 binning
and analysis of time-lapse movies was done using ImageJ
software where the time between nuclear envelope break-
down (NEBD) and anaphase-onset was determined.
For live-cell fluorescent imaging of cyclin B1-mCherry
degradation above described system was used. Imaged were
acquired every 5 min 1×1 binning (1,024×1,024 pixels).
Sample illumination was kept to a minimum to prevent
perturbing cell viability.
Live-cell imaging of eYFP-FKBP-MAD1 was performed
on a personal DeltaVision system (Applied Precision/GE
Healthcare) equipped with a Coolsnap HQ2 CCD camera
(Photometrics) and Insight solid-state illumination
(Applied Precision/GE Healthcare). Images were acquired
every 5 min using a 100×1.4 NA UPlanSApo objective
Fig. 3 FRB-MAD1 can be recruited to metaphase kinetochores without
affecting chromosome alignment. a, b Time-lapse analysis of MAD1
recruitment (a) or chromosome alignment (b). HeLa Flp-in cells
expressing MIS12-FRB-tagRFP (a) or MIS12-FRB-FLAG (b) were
induced to express the eYFP-FKBP-MAD1 variants by addition of
doxycycline for 4 h. MG132 was added for 45 min and metaphase cells
were selected for time-lapse imaging. a DMSO or rapamycin were added
as indicated and cells were imaged every 5 min. bHeLa Flp-in cells were
infected with H2B-mCherry BacMam virus for 24 h and treated as in (a).
Metaphase cells were selected and imaged every 10 min. Shown are
single plane images of DIC and eYFP and max projections of H2B-
mCherry. c Upper panels: Immunostainings of BUB1 (left), BUBR1
(middle), and MAD2 (right) in combination with kinetochores (CENP-
C) and eYFP-FKBP-MAD1 (eYFP) of HeLa Flp-in cells expressing
MIS12-FRB-FLAG and induced to express eYFP-FKBP-MAD1WT by
addition of doxycycline for 4.5 h. MG132 and DMSO or rapamycin were
added for 20 min after cells had reached metaphase, for the duration of 30
minutes. Lower graphs: Quantifications of the corresponding
immunostainings. Each dot represents total kinetochore intensity of a
single cell (arbitrary units as a ratio over CENP-C). Averages and stan-
dard deviation are indicated.
476 Chromosoma (2014) 123:471–480
(Olympus) at 2×2 binning. Twelve-micrometer-thick op-
tical sections were acquired at 4 μm steps and YFP
illumination was set to 100 ms and 50 % neutral density
(ND) filter, mCherry illumination was set to 150 ms and
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50 % ND. For H2B-mCherry, live-cell imaging the
mCherry illumination was set to 50 ms and 50 % ND.
Images were deconvolved using standard settings in
SoftWorx (Applied Precision/GE Healthcare). For imag-
ing analysis, Image J was used and figure preparation was
done in Illustrator CS5 (Adobe).
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Fig. 4 MAD1 recruitment to metaphase kinetochores re-activates the
SAC. a, b Time-lapse analysis of cyclin B1-mCherry. HeLa Flp-in cells
expressing MIS12-FRB-FLAG and cyclin B1-mCherry were induced to
express the FKBP-MAD1 variants by addition of doxycycline immedi-
ately following release from a single thymidine block and imaging started
8 h after that. Rapamycin/DMSOwere added during a mitotic wave, after
which cells were monitored for cyclin B1-mCherry fluorescence every
5 min. Fluorescent intensity on y-axis is relative to intensity at NEBD. b
500 nM reversine was added 102 min after rapamycin. a, b A
proportion of cells showed cyclin B1 stabilization after initial
decline only in FKBP-MAD1WT cells treated with rapamycin (orange
traces). Those traces are also separately depicted in right graphs. Exper-
iments were performed four (a) or two (b) times, and one representative
experiment is shown in each graph
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Immunoblotting
Cells were blocked in thymidine for 20 h and released for 16 h
in presence of nocodazole and doxycycline when indicated.
Mitotic cells were collected by shake-off and cells were lysed
in 2× Laemmli sample buffer. Cell lysates were boiled for
5 min and separated on a 10 % SDS-PAGE gel. Proteins were
transferred to nitrocellulose membranes and membranes were
blocked in 5 % milk/TBS-0.1 % Tween-20 for 30 min. The
following primary antibodies were used: anti-tubulin (clone
B-5-1-2; Sigma; T5168, 1:10.000), anti-MAD1 (Fig. 1b and
S1B: M-300; Santa Cruz; sc-67337 1:1,000; Fig. S1A: Sigma
M-8069, 1:1,000) and anti-cyclin B1 (GNS1; Santa Cruz; sc-
245, 1:1,000). Detection of proteins was done with HRP-
conjugated secondary antibodies (Bio-Rad) and chemilumi-
nescence. Adobe Photoshop and Illustrator were used to create
the figure.
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